Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
A phase 3 trial of Aminolevulinic acid and Methyl aminolevulinate in Basal cell carcinoma, run by Biofrontera Bioscience GmbH, completed.
Overview
Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy is a phase 3 interventional study registered as NCT02144077 by Biofrontera Bioscience GmbH, with 281 participants recorded, started 2014-01-28 and reaching its primary completion in 2015-11-17. Interventions recorded: BF-200 ALA, methyl-aminolevulinate. Conditions recorded: Basal Cell Carcinoma (BCC).
Linked to the drug Methyl aminolevulinate because the registry names it among its interventions and Basal cell carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
Shares Aminolevulinic acid (topical, for photodynamic therapy) and the tag pipeline.
- TrialAdjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Shares Aminolevulinic acid (topical, for photodynamic therapy) and the tag pipeline.
- TrialClinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)
Shares Basal cell carcinoma and the tag pipeline.
- TrialPlacebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)
Shares Basal cell carcinoma and the tag pipeline.
- TrialFlash Radiotherapy for Skin Cancer
Shares Basal cell carcinoma and the tag pipeline.
- TrialL19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Shares Basal cell carcinoma and the tag pipeline.
- TrialL19IL2/TNF in Patients With Basal Cell Carcinoma
Shares Basal cell carcinoma and the tag pipeline.
- TrialEfficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Shares Basal cell carcinoma and the tag pipeline.